Mon, Sep 15, 2014, 1:21 AM EDT - U.S. Markets open in 8 hrs 9 mins

Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • slumdawg2011 slumdawg2011 May 19, 2013 9:13 PM Flag

    How do you feel about the other ADC?

    No, not CLDX, bayou the CLDX pimp! PGNX with their anti PSMA-ADC! How do people feel about the scientific basis and market competitiveness?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Competitiveness as compared to which drug? Since it's only in phase 2, it's so far not in a position to be competitive. But the science seems sound, as far as that goes. In vitro testing suggests that a high level of expression of PSMA is more likely to be associated with drug efficacy. The ADC showed a high level of activity against PC xenografts. I beleive there is a companion imaging compound as well.

      The limited phase I data available didn't suggest the drug is a home run, but interesting activity was seen as reflected by decreases in PSA and CTCs. Neutropenia may be a concern.

 
SGEN
41.39+0.49(+1.20%)Sep 12 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT